| Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019 QL Zeng, ZJ Yu, JJ Gou, GM Li, SH Ma, GF Zhang, JH Xu, WB Lin, GL Cui, ... The Journal of infectious diseases 222 (1), 38-43, 2020 | 384 | 2020 |
| Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study QL Zeng, GH Xu, JY Zhang, W Li, DW Zhang, ZQ Li, HX Liang, CX Li, ... Journal of Hepatology 66 (6), 1123-1129, 2017 | 72 | 2017 |
| Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8+ T cells in chronic hepatitis C patients QL Zeng, B Yang, HQ Sun, GH Feng, L Jin, ZS Zou, Z Zhang, JY Zhang, ... Molecules and cells 37 (1), 66-73, 2014 | 72 | 2014 |
| Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming? QL Zeng, ZQ Li, HX Liang, GH Xu, CX Li, DW Zhang, W Li, CY Sun, ... Journal of hepatology 65 (5), 1068-1069, 2016 | 51 | 2016 |
| Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p Z Li, Y Hu, Q Zeng, H Wang, J Yan, H Li, Z Yu Cancer cell international 19, 1-11, 2019 | 50 | 2019 |
| Sofosbuvir and ABT-450: terminator of hepatitis C virus? QL Zeng, JY Zhang, Z Zhang, LF Wang, FS Wang World journal of gastroenterology: WJG 19 (21), 3199, 2013 | 46 | 2013 |
| Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective, observational study QL Zeng, ZJ Yu, F Ji, GM Li, GF Zhang, JH Xu, ZM Chen, GL Cui, W Li, ... Clinical Infectious Diseases 73 (9), e3324-e3332, 2021 | 45 | 2021 |
| Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors XX Zhang, LF Wang, L Jin, YY Li, SL Hao, YC Shi, QL Zeng, ZW Li, ... World journal of gastroenterology: WJG 21 (12), 3554, 2015 | 37 | 2015 |
| Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis Z Li, Y Liu, J Yan, Q Zeng, Y Hu, H Wang, H Li, J Li, Z Yu Aging (albany NY) 12 (3), 2485, 2020 | 33 | 2020 |
| Clinical course and treatment efficacy of COVID‐19 near Hubei Province, China: a multicentre, retrospective study QL Zeng, GM Li, F Ji, SH Ma, GF Zhang, JH Xu, WB Lin, GH Xu, ... Transboundary and Emerging Diseases 67 (6), 2971-2982, 2020 | 31 | 2020 |
| Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study J Wang, Q Zhang, J Ai, D Liu, C Liu, H Xiang, Y Gu, Y Guo, J Lv, Y Huang, ... Hepatology International 16 (3), 691-701, 2022 | 30 | 2022 |
| Interleukin‐21 mediates hepatitis B virus‐associated liver cirrhosis by activating hepatic stellate cells G Feng, JY Zhang, QL Zeng, X Yu, Z Zhang, S Lv, X Xu, FS Wang Hepatology Research 44 (10), E198-E205, 2014 | 30 | 2014 |
| MiR‐19a affects hepatocyte autophagy via regulating lncRNA NBR2 and AMPK/PPARα in D‐GalN/Lipopolysaccharide‐Stimulated hepatocytes YM Liu, JH Ma, QL Zeng, J Lv, XH Xie, YJ Pan, ZJ Yu Journal of cellular biochemistry 119 (1), 358-365, 2018 | 29 | 2018 |
| Long noncoding RNA HOTTIP promotes mouse hepatic stellate cell activation via downregulating miR-148a Z Li, J Wang, Q Zeng, C Hu, J Zhang, H Wang, J Yan, H Li, Z Yu Cellular Physiology and Biochemistry 51 (6), 2814-2828, 2019 | 27 | 2019 |
| HCV-specific interleukin-21+ CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients G Feng, JY Zhang, QL Zeng, L Jin, J Fu, B Yang, Y Sun, T Jiang, X Xu, ... Molecules and cells 36, 362-367, 2013 | 26 | 2013 |
| Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients P Xia, XD Xing, CX Yang, XJ Liao, FH Liu, HH Huang, C Zhang, JW Song, ... Military Medical Research 9 (1), 24, 2022 | 23 | 2022 |
| AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy YM Liu, J Lv, QL Zeng, S Shen, JY Xing, YY Zhang, ZH Zhang, ZJ Yu Experimental Cell Research 358 (2), 335-342, 2017 | 23 | 2017 |
| The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and … ZQ Li, CL Hu, P Yu, XY Gu, JJ Zhang, H Li, HY Zhang, J Lv, YM Liu, ... Clinics and Research in Hepatology and Gastroenterology 41 (3), 311-318, 2017 | 23 | 2017 |
| LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells Y Chen, Q Zeng, X Liu, J Fu, Z Zeng, Z Zhao, Z Liu, W Bai, Z Dong, H Liu, ... Cancer Management and Research, 4421-4438, 2018 | 22 | 2018 |
| Short-term peginterferon-induced high functional cure rate in inactive chronic hepatitis B virus carriers with low surface antigen levels QL Zeng, ZJ Yu, J Shang, GH Xu, CY Sun, N Liu, CX Li, J Lv, YM Liu, ... Open Forum Infectious Diseases 7 (6), ofaa208, 2020 | 21 | 2020 |
